TY - JOUR

T1 - Provision of pharmaceutical care by community pharmacists across Europe

T2 - Is it developing and spreading?

AU - Costa, Filipa A

AU - Scullin, Claire

AU - Al-Taani, Ghaith

AU - Hawwa, Ahmed F

AU - Anderson, Claire

AU - Bezverhni, Zinaida

AU - Binakaj, Zahida

AU - Cordina, Maria

AU - Foulon, Veerle

AU - Garcia de Bikuña, Borja

AU - de Gier, Han

AU - Granås, Anne Gerd

AU - Grinstova, Olga

AU - Griese-Mammen, Nina

AU - Grincevicius, Jonas

AU - Grinceviciene, Svitrigaile

AU - Kaae, Susanne

AU - Kubiliene, Loreta

AU - Mariño, Eduardo L

AU - Martins, Silvia

AU - Modamio, Pilar

AU - Nadin, Giancarlo

AU - Nørgaard, Lotte Stig

AU - Obarcanin, Emina

AU - Tadic, Ivana

AU - Tasic, Ljiljana

AU - McElnay, James C

AU - Hersberger, Kurt E

AU - Westerlund, Tommy

N1 - © 2017 John Wiley & Sons, Ltd.

PY - 2017/12/21

Y1 - 2017/12/21

N2 - RATIONALE, AIMS, AND OBJECTIVES: Pharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe.METHOD: A cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006.RESULTS: The provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n = 8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education.CONCLUSIONS: The present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.

AB - RATIONALE, AIMS, AND OBJECTIVES: Pharmaceutical care involves patient-centred pharmacist activity to improve medicines management by patients. The implementation of this service in a comprehensive manner, however, requires considerable organisation and effort, and indeed, it is often not fully implemented in care settings. The main objective was to assess how pharmaceutical care provision within community pharmacy has evolved over time in Europe.METHOD: A cross-sectional questionnaire-based survey of community pharmacies, using a modified version of the Behavioural Pharmaceutical Care Scale (BPCS) was conducted in late 2012/early 2013 within 16 European countries and compared with an earlier assessment conducted in 2006.RESULTS: The provision of comprehensive pharmaceutical care has slightly improved in all European countries that participated in both editions of this survey (n = 8) with progress being made particularly in Denmark and Switzerland. Moreover, there was a wider country uptake, indicating spread of the concept. However, due to a number of limitations, the results should be interpreted with caution. Using combined data from participating countries, the provision of pharmaceutical care was positively correlated with the participation of the community pharmacists in patient-centred activities, routine use of pharmacy software with access to clinical data, participation in multidisciplinary team meetings, and having specialized education.CONCLUSIONS: The present study demonstrated a slight evolution in self-reported provision of pharmaceutical care by community pharmacists across Europe, as measured by the BPCS. The slow progress suggests a range of barriers, which are preventing pharmacists moving beyond traditional roles. Support from professional bodies and more patient-centred community pharmacy contracts, including remuneration for pharmaceutical care services, are likely to be required if quicker progress is to be made in the future.

KW - Journal Article

UR - https://onlinelibrary.wiley.com/doi/full/10.1111/jep.12783

U2 - 10.1111/jep.12783

DO - 10.1111/jep.12783

M3 - Journal article

C2 - 28762651

VL - 23

SP - 1336

EP - 1347

JO - Journal of Evaluation in Clinical Practice

JF - Journal of Evaluation in Clinical Practice

SN - 1356-1294

IS - 6

ER -